Search

Activity landscape Activity cliffs Interaction cliffs Protein-ligand interaction fingerprints Kinase inhibitors SAS maps

Neuroblastoma (NB) is the most common and deadly solid tumour in children. Despite the development of new treatment options for high-risk NB, over half of patients relapse and five-year survival remains at 40-50%. Therefore...

ALK Kinase inhibitors Neuroblastoma

In the current work, a hybridisation strategy was adopted between the privileged building blocks, benzofuran and piperazine, with the aim of designing novel CDK2 type II inhibitors. The hybrid structures were linked to different...

Kinase inhibitors apoptotic agents benzofuran synthesis Molecular docking pancreatic cancer Antineoplastic Agents Benzofurans Cell Line Tumor Cell Proliferation Drug Screening Assays Antitumor Molecular Docking Simulation Molecular Structure Protein Kinase Inhibitors Structure-Activity Relationship

The small molecule belumosudil was initially identified as a selective inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2) and has recently been approved for the treatment of graft-versus-host disease. However, recent...

CK2α inhibition ROCK2 inhibition Rho-associated coiled-coil kinase 2 belumosudil Kinase inhibitors selective inhibitors Acetamides Adenosine Triphosphate covid-19 Casein Kinase II Crystallography X-Ray Humans rho-Associated Kinases

BACKGROUND: Aurora A (AurA) kinase is a key mitotic protein implicated in cancer. Several small molecule inhibitors targeting the ATP binding site of this enzyme are in various stages of clinical development. However, these...

AURKA AurA-TPX2 inhibition Aurora A TPX2 allosteric inhibition Kinase inhibitors proteinprotein interaction type IV inhibitors. Allosteric Regulation Allosteric Site Anacardic Acids Aurora Kinase A Cell Cycle Proteins Cell Line Tumor Felodipine Humans Microtubule-Associated Proteins Nuclear Proteins Protein Binding Protein Kinase Inhibitors